Table 3 Antimicrobial susceptibility profile of Gram-negative bacterial isolates (N = 111)
Antibiotics | Bacterial isolates | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
K. pneumoniae (n = 33) | P. aeruginosa (n = 8) | E. coli (n = 17) | Serratia spp (n = 10) | H. influenzae (n = 6) | E. aerogenes (n = 2) | Proteus spp (n = 1) | LFGNRs (n = 2) | |||||||||
S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | |
GEN | 31 (93.9) | 2 (6.1) | 8 (100.0) | 0 (0) | 9 (52.9) | 8 (47.1) | 9 (90.0) | 1 (10.0) | N/A | N/A | 2 (100.0) | 0 (0) | 1 (100.0) | 0 (0) | 2 (100.0) | 0 (0) |
CAF | 29 (87.9) | 4 (12.1) | 7 (87.5) | 1 (12.5) | 16 (94.1) | 1 (5.9) | 9 (90.0) | 1 (10.0) | 5 (83.3) | 1 (16.7) | 2 (100.0) | 0 (0) | 1 (100.0) | 0 (0) | 2 (100.0) | 0 (0) |
CTR | 29 (87.9) | 4 (12.1) | 5 (62.5) | 3 (37.5) | 15 (88.2) | 2 (11.8) | 8 (80.0) | 2 (20.0) | 6 (100.0) | 0(0) | 2 (100.0) | 0 (0) | 1 (100.0) | 0 (0) | 2 (100.0) | 0 (0) |
AMP | 12 (36.4) | 21 (63.6) | 0(0) | 8 (100.0) | 2 (11.8) | 15 (88.2) | 3 (30.0) | 7 (70.0) | 0 (0) | 6 (100.0) | 1 (50.0) | 1 (50.0) | 1 (100.0) | 0 (0) | 1 (50.0) | 1 (50.0) |
COT | 25 (75.8) | 8 (24.2) | 5 (62.5) | 3 (37.5) | 14 (82.4) | 3 (17.6) | 6 (60.0) | 4 (40.0) | N/A | N/A | 1 (50.0) | 1 (50.0) | 1 (100.0) | 0 (0) | 2 (100.0) | 0 (0) |
CAZ | 30 (90.9) | 3 (9.1) | N/A | N/A | 16 (94.1) | 1 (5.9) | 8 (80.0) | 2 (20.0) | 5 (83.3) | 1 (16.7) | 2 (100.0) | 0 (0) | 1 (100.0) | 0 (0) | 2 (100.0) | 0 (0) |
TE | 26 (78.8) | 7 (21.2) | 6 (75.0) | 2 (25.0) | 15 (88.2) | 2 (11.8) | 8 (80) | 2 (20) | N/A | N/A | 2 (100) | 0 (0) | 1 (100) | 0 (0) | 2 (100) | 0 (0) |